INFLUENCE OF CYP3A4, CYP3A5, POR AND ABCB1 GENES ON TACROLIMUS RESPONSE IN LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Naldi, Graziella D'A. R. [1 ]
Pereira, Thales Dalessandro [2 ]
Fossaluza, Victor [2 ]
Nacif, Lucas [1 ]
Carneiro D'Albuquerque, Luiz Augusto [1 ]
Carrilho, Flair J.
Ono, Suzane Kioko [1 ]
机构：
[1] Univ Sao Paulo, Dept Gastroenterol, Sch Med, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Math & Stat, Sao Paulo, Brazil
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4211
引用
收藏
页码：S1281 / S1282
页数：2
相关论文
共 50 条
  • [1] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
  • [2] Influence of Cyp3A4, Cyp3A5 and ABCB1 Polymorphisms on Tacrolimus Concentrations and Rejection Risk in Indian Kidney Transplant Recipients
    Mukkavilli, Kamal Kiran
    Khan, Mohammed Shoeb A.
    Donakonda, Arun Kumar
    Gangisetty, Suma Rama Gopal
    Poojaveli, Dileena
    INDIAN JOURNAL OF TRANSPLANTATION, 2024, 18 (01) : 42 - 45
  • [3] POLIMORPHISMS IN THE CYP3A4, CYP3A5 AND ABCB1 GENES MODIFY TACROLIMUS PHARMACOKINETICS AND PHARMACODYNAMICS IN RENAL TRANSPLANT
    Garcia, M.
    Macias, R. M.
    Caravaca, F.
    Benitez, J.
    Cubero, J.
    Carrillo, J. A.
    Gervasini, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 64 - 64
  • [4] IMPACT OF CYP3A5, CYP3A4, AND ABCB1 GENOTYPES ON TACROLIMUS DOSING AND MONITORING IN LIVER TRANSPLANT PATIENTS
    Ladd, Alexandra
    Pahim, Isabella Angeli
    Warren, Curtis
    Duarte, Sergio
    Zarrinpar, Ali
    HEPATOLOGY, 2022, 76 : S1284 - S1285
  • [5] IMPACT OF DONOR AND RECIPIENT CYP3A5, CYP3A4 AND ABCB1 POLYMORPHISMS ON TACROLIMUS PHARMACOKINETICS AND CLINICAL OUTCOME IN LIVER TRANSPLANT RECIPIENTS
    Falconer, Stuart
    Cryer, Claire
    Turner, David
    Oniscu, Gabriel
    TRANSPLANT INTERNATIONAL, 2013, 26 : 91 - 91
  • [6] Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients
    Debette-Gratien, Marilyne
    Woillard, Jean-Baptiste
    Picard, Nicolas
    Sebagh, Mylene
    Loustaud-Ratti, Veronique
    Sautereau, Denis
    Samuel, Didier
    Marquet, Pierre
    TRANSPLANTATION, 2016, 100 (10) : 2129 - 2137
  • [7] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    T Vanhove
    P Annaert
    D Lambrechts
    D R J Kuypers
    The Pharmacogenomics Journal, 2017, 17 : 556 - 562
  • [8] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    Vanhove, T.
    Annaert, P.
    Lambrechts, D.
    Kuypers, D. R. J.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (06): : 556 - 562
  • [9] CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients
    Kurzawski, Mateusz
    Dabrowska, Justyna
    Dziewanowski, Krzysztof
    Domanski, Leszek
    Peruzynska, Magdalena
    Drozdzik, Marek
    PHARMACOGENOMICS, 2014, 15 (02) : 179 - 188
  • [10] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
12345